Health · NZ ·
Pembrolizumab Plus Radiation Fails to Improve Recurrence-Free Survival in Early-Stage High-Intermediate–Risk d
OncLive · Health
Published

Read it at the source
OncLive↗We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.







